Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001437749-24-037352
Filing Date
2024-12-12
Accepted
2024-12-12 16:15:29
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM 425 pirs20241212c_425.htm 425 51110
2 EXHIBIT 3.1 ex_756977.htm EX-3.1 3342
3 EXHIBIT 3.2 ex_756978.htm EX-3.2 2146
4 EXHIBIT 10.1 ex_756979.htm EX-10.1 97426
5 a01.jpg GRAPHIC 99242
6 a02.jpg GRAPHIC 201998
7 a03.jpg GRAPHIC 176792
8 a04.jpg GRAPHIC 175971
9 b01.jpg GRAPHIC 99020
10 b02.jpg GRAPHIC 199758
  Complete submission text file 0001437749-24-037352.txt   1467781
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filed by) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Subject) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-37471 | Film No.: 241545000
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)